Please login to the form below
prevention
This page shows the latest prevention news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly reports first results for COVID-19 targeting antibody
Lilly recently launched a phase 3 study of the antibody for the prevention of COVID-19 in residents and staff at nursing homes across the US, as well as further studies
Latest news
-
Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19
As a company, we’ve moved quickly to develop and evaluate medicines for patients for the prevention and treatment of COVID-19,” said Daniel Skovronsky, senior vice president and chief scientific
-
Regeneron launches phase 3 COVID-19 antibody trial in the UK
Regeneron is also testing the drug in a phase 3 trial for the prevention of COVID-19 in household contacts in infected individuals. ... As part of the deal, Roche and Regeneron are jointly funding and executing the ongoing phase 3 prevention trial, as
-
Valneva announces major COVID-19 vaccine partnership with UK government
Valneva, a specialty vaccine company focused on the prevention of diseases with major unmet needs, will supply 60 million doses of its inactivated COVID-19 vaccine, VLA2001, if vaccine development is
-
Moderna’s COVID-19 vaccine shows promise in older adults
According to the US Centers for Disease Control and Prevention, it can also prove more challenging to find a vaccine that is effective for older adults.
-
Novavax CEO anticipates filing COVID-19 vaccine for approval in December
Nicholas Kitchin, a Pfizer vaccine research and development scientist, revealed the enrolment status of the BioNTech-partnered study at the Centers for Disease Control and Prevention’s Advisory Committee on Immunization
More from news
Approximately 5 fully matching, plus 783 partially matching documents found.
Latest Intelligence
-
Has AI been the key to tackling the COVID-19 pandemic?
In the early stages of the outbreak, it announced a ‘suite of global disease prevention maps, as well as a survey tool for identifying coronavirus hotspots’.
-
The far-reaching impact of the COVID-19 pandemic on clinical trials
Regulatory authorities are actively supporting trials for the treatment or prevention of COVID-19.
-
Cortellis Drugs to Watch in 2020 report
1. Rimegepant from BioHaven Pharmaceuticals is an antagonist of calcitonin gene-related peptide (CGRP), recently approved in the US for the acute treatment of migraine, with prevention trials also ongoing.
-
Blockchain: bringing truth back to the internet?
for Disease Control and Prevention’s monitoring of a country’s health or insurers using it to process claims of those who’ve contracted COVID-19.
-
Mapping the patient journey and minding the gap
opportunity, to caring for consumers right through the disease life cycle; prevention, diagnosis, management and maintenance.
More from intelligence
Approximately 2 fully matching, plus 88 partially matching documents found.
Latest appointments
-
Four Health announces a pair of internal promotions
role of the NHS in public health and prevention medicine.
-
New hires at bluebird bio, BioNTech and Provention Bio
In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy
-
Destiny Pharma appoints new CEO
As we move forward, Neil’s extensive leadership experience in clinical stage biopharmaceutical companies will be investigating XF-73 as a potential first-in-class drug for the prevention of
-
New health ministers and re-appointments after reshuffle
resistance, cancer, dementia, diabetes as well as issues around vaccination and the prevention of long-term conditions.
-
Merck names head of strategic communications
Prior to this role, she served as director of the US Centers for Disease Control and Prevention from 2002 and was director of the Division of Healthcare Quality Promotion before that.
More from appointments
Approximately 1 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
In the precision medicine era, the line between products and services is blurred
Personalised and precision medicines are exciting fields that focus on the development of treatment and prevention strategies for a single patient or patient group.
-
Tackling obesity via green prescribing: A piece of cake or a half-baked strategy?
It is a proactive approach, that fits with the wider Government strategies aimed at preventing the development of serious health conditions, as outlined in the Advancing our Health: Prevention in the ... The approach is potentially game-changing, if
-
Hamell selected by PM Society's 'Creativity for Good' initiative
Hamell have been selected by the PM Society’s charity partner PAPYRUS Prevention of Young Suicide, to develop a fundraising campaign as part of their 'Creativity for Good' initiative. ... PAPYRUS is the leading national charity dedicated to the
-
Understanding COVID-19 and varying responses across the globe
The routes of transmission largely determine prevention strategies. To prevent the spread of the disease it has been advised to thoroughly wash your hands, maintain distance with other people and avoid
-
EPG Health launches Medthority, a medical website personalised for doctors and tailored for pharma
These are self-contained, disease and condition specific educational resources for topics including stroke prevention, transplantation and prostate cancer.
More from PMHub
Approximately 1 fully matching, plus 49 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
